As Shreehas Tambe, Chief Executive Officer and Managing Director of Biocon Biologics Limited, noted regarding demand and growth potential for GLP-1 therapies, There will be a requirement for significantly higher volumes and Biocons fermentation capability will give us a significant advantage. India leads with a CAGR of 8.4%, driven by a large diabetic population and increasing demand for effective treatments
If hair loss does occur, remember that telogen effluvium is typically temporary
Are there foods I should avoid while taking semaglutide
Genetic disorders, certain medical conditions, or certain medications can cause a deficiency in carnitine in the body by interfering with its uptake
This makes semaglutide considerably more travel-friendly and more forgiving of brief storage lapses
The primary endpoint, major adverse cardiovascular events (MACE), was the time to first occurrence of a three-part composite outcome which included CV death, non-fatal myocardial infarction (MI) and non-fatal stroke